POSTS TAGGED AS biologics

Patenting “Biosimilars”

Several bills now in Congress could result in a fundamental change to patenting biologics (such as monoclonal antibodies).  One bill [MORE]

Clinical Trial Participation

With a noticeable shift from small molecules to biologicals, it’s no surprise that The Philadelphia Business Journal reports that biopharma [MORE]

Pfizer’s Business Refocus

Pfizer believes that its highest payoff for R&D will be in oncology, pain, inflammation, diabetes, Alzheimer’s’ disease and [MORE]